Denali Therapeutics Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $201.5M | $387.6M | $205.3M | $91.0M | $141.2M | $56.9M | $175.0M | $90.6M |
| Accounts Receivable | $3.9M | — | $0 | — | — | — | — | — |
| Inventory | $4.1M | — | $0 | — | — | — | — | — |
| Total Current Assets | $753.9M | $1.02B | $900.7M | $882.6M | $934.7M | $878.6M | $864.4M | $868.8M |
| Property, Plant & Equipment | $49.9M | $51.7M | $52.4M | $53.7M | $58.7M | $57.8M | $55.2M | $50.8M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $35.3M | $36.0M | $0 | — | — | — | — | — |
| Total Assets | $1.16B | $1.27B | $1.14B | $1.06B | $1.17B | $1.27B | $1.37B | $1.45B |
| Liabilities | ||||||||
| Accounts Payable | $11.8M | $40.4M | $505.0K | $6.7M | $10.8M | $8.5M | $11.1M | $9.6M |
| Total Current Liabilities | $90.1M | $110.2M | $98.4M | $90.1M | $91.1M | $91.9M | $102.2M | $87.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $322.8M | $339.9M | $131.1M | $129.4M | $139.2M | $148.7M | $144.5M | $135.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-2.31B | $-2.18B | $-2.05B | $-1.92B | $-1.80B | $-1.67B | $-1.54B | $-1.42B |
| Total Stockholders' Equity | $835.2M | $926.1M | $1.01B | $926.2M | $1.03B | $1.12B | $1.23B | $1.32B |